BIOMAT Database Logo BIOMAT Database Logo

Elevated serum aminoterminal procollagen type III peptide in methotrexate-induced hepatic fibrosis. 1986

G M Fairris, and B Brooks, and A Tanner

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011347 Procollagen A biosynthetic precursor of collagen containing additional amino acid sequences at the amino-terminal and carboxyl-terminal ends of the polypeptide chains. Protocollagen,Procollagen Type M
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

G M Fairris, and B Brooks, and A Tanner
Serum levels of aminoterminal type III procollagen peptide in normal subjects and hepatic fibrosis.
December 1985, Gastroenterologia Japonica,
G M Fairris, and B Brooks, and A Tanner
Elevated serum aminoterminal procollagen type-III-peptide parallels collagen accumulation in rats with secondary biliary fibrosis.
July 1996, Journal of hepatology,
G M Fairris, and B Brooks, and A Tanner
Aminoterminal propeptide of type III procollagen in methotrexate-induced liver fibrosis and cirrhosis.
September 1988, The British journal of dermatology,
G M Fairris, and B Brooks, and A Tanner
Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen.
March 2005, The British journal of dermatology,
G M Fairris, and B Brooks, and A Tanner
Serum aminoterminal propeptide of type III procollagen in the management of methotrexate-induced fibrogenesis.
July 1992, Journal of the American Academy of Dermatology,
G M Fairris, and B Brooks, and A Tanner
Increased serum procollagen III aminoterminal peptide in myelofibrosis.
December 1983, American journal of hematology,
G M Fairris, and B Brooks, and A Tanner
Serum procollagen type III aminoterminal peptide in primary fibromyalgia (fibrositis syndrome)
December 1988, British journal of rheumatology,
G M Fairris, and B Brooks, and A Tanner
Serum type III procollagen peptide, dynamic liver function tests and hepatic fibrosis in psoriatic patients receiving methotrexate.
January 1990, The British journal of dermatology,
G M Fairris, and B Brooks, and A Tanner
Serum aminoterminal type III procollagen peptide in inflammatory and degenerative rheumatic disorders.
March 1988, Clinical rheumatology,
G M Fairris, and B Brooks, and A Tanner
[Serum aminoterminal procollagen type-III peptide in the diagnosis of chronic hepatopathies].
May 1992, Medicina clinica,
Copied contents to your clipboard!